000153.SZ
Anhui Fengyuan Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.92
−2.47%Year over year
Reported trailing growth
- Revenue
- -8.6%
- EBITDA
- —
- EBIT
- -30.6%
- EPS
- -35.2%
- Free cash flow
- +48.3%
- Operating cash flow
- -5.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.2%
- EBITDA
- -5.3%
- EBIT
- -14.6%
- Net income
- -13.7%
- EPS
- -24.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026